This inventor holds 1 USPTO granted patent. Top assignee: Arvinas Operations, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Taavi K Neklesa: Innovator in Protein-Protein Interaction Inducing Technology
Introduction
Taavi K Neklesa is a prominent inventor based in Orange, CT (US). He has made significant contributions to the field of biotechnology, particularly in the area of protein interactions. His innovative work has led to the development of a unique technology that enhances our understanding of protein behavior.
Latest Patents
Taavi K Neklesa holds a patent for his groundbreaking invention titled "Protein-Protein Interaction Inducing Technology." This patent is based on the unexpected discovery that a ligand molecule with specific characteristics can bind to two protein molecules simultaneously. This binding facilitates the formation of a transient or stable protein-protein interaction complex. The technology provides a method to design and identify tripartite or bifunctional compounds that can induce protein-protein interactions in various contexts. The composition developed for this purpose significantly increases the binding potency of the ligand by contributing additional stabilization energy to the complex.
Career Highlights
Taavi K Neklesa has established himself as a key figure in the biotechnology sector. He is currently associated with Arvinas Operations, Inc., where he continues to innovate and develop new technologies. His work has garnered attention for its potential applications in drug development and therapeutic interventions.
Collaborations
Taavi collaborates with talented professionals in his field, including his coworker Hanqing Dong. Their combined expertise contributes to the advancement of research and development in protein interactions.
Conclusion
Taavi K Neklesa's contributions to protein-protein interaction technology represent a significant advancement in biotechnology. His innovative approach and dedication to research continue to pave the way for future discoveries in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
